For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Teladoc Health Inc’s stock clocked out at $7.62, down -0.91% from its previous closing price of $7.69. In other words, the price has decreased by -$0.91 from its previous closing price. On the day, 2.85 million shares were traded. TDOC stock price reached its highest trading level at $7.73 during the session, while it also had its lowest trading level at $7.5709.
Ratios:
To gain a deeper understanding of TDOC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.90. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 2.61. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.74.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on December 09, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $8.50. On November 13, 2025, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $8. On July 25, 2025, Mizuho started tracking the stock assigning a Neutral rating and target price of $10.Mizuho initiated its Neutral rating on July 25, 2025, with a $10 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 11 ’25 when DIVITA CHARLES III sold 17,138 shares for $7.63 per share. The transaction valued at 130,837 led to the insider holds 201,036 shares of the business.
DIVITA CHARLES III bought 17,138 shares of TDOC for $130,837 on Dec 11 ’25. On Dec 03 ’25, another insider, Rodrigues Fernando M., who serves as the President of BetterHelp of the company, sold 4,209 shares for $7.48 each. As a result, the insider received 31,483 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TDOC now has a Market Capitalization of 1352347392 and an Enterprise Value of 1668168320. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.53 while its Price-to-Book (P/B) ratio in mrq is 0.97. Its current Enterprise Value per Revenue stands at 0.66 whereas that against EBITDA is 103.164.
Stock Price History:
The Beta on a monthly basis for TDOC is 2.04, which has changed by -0.268714 over the last 52 weeks, in comparison to a change of 0.14045572 over the same period for the S&P500. Over the past 52 weeks, TDOC has reached a high of $15.21, while it has fallen to a 52-week low of $6.35. The 50-Day Moving Average of the stock is -4.65%, while the 200-Day Moving Average is calculated to be -2.21%.
Shares Statistics:
It appears that TDOC traded 7.49M shares on average per day over the past three months and 3827020 shares per day over the past ten days. A total of 177.35M shares are outstanding, with a floating share count of 175.50M. Insiders hold about 1.11% of the company’s shares, while institutions hold 70.48% stake in the company. Shares short for TDOC as of 1764288000 were 25717472 with a Short Ratio of 3.43, compared to 1761868800 on 23659596. Therefore, it implies a Short% of Shares Outstanding of 25717472 and a Short% of Float of 16.2.
Earnings Estimates
The firm’s stock currently is rated by 4.0 analysts. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.3 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$0.65 and -$1.25 for the fiscal current year, implying an average EPS of -$0.99. EPS for the following year is -$0.88, with 5.0 analysts recommending between -$0.79 and -$0.99.
Revenue Estimates
In. The current quarter, 25 analysts expect revenue to total $635.06M. It ranges from a high estimate of $645.19M to a low estimate of $628.36M. As of. The current estimate, Teladoc Health Inc’s year-ago sales were $640.49MFor the next quarter, 25 analysts are estimating revenue of $632.6M. There is a high estimate of $650.7M for the next quarter, whereas the lowest estimate is $621.7M.
A total of 25 analysts have provided revenue estimates for TDOC’s current fiscal year. The highest revenue estimate was $2.53B, while the lowest revenue estimate was $2.52B, resulting in an average revenue estimate of $2.52B. In the same quarter a year ago, actual revenue was $2.57BBased on 25 analysts’ estimates, the company’s revenue will be $2.55B in the next fiscal year. The high estimate is $2.62B and the low estimate is $2.51B.
